Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 304

1.

Validation and uncertainty estimation for trace amounts determination of 25 drugs used in hospital chemotherapy compounding units.

Guichard N, Rudaz S, Bonnabry P, Fleury-Souverain S.

J Pharm Biomed Anal. 2019 Aug 5;172:139-148. doi: 10.1016/j.jpba.2019.04.042. Epub 2019 Apr 22.

PMID:
31035095
2.
3.

Determination of 16 antineoplastic drugs by capillary electrophoresis with UV detection: Applications in quality control.

Guichard N, Ogereau M, Falaschi L, Rudaz S, Schappler J, Bonnabry P, Fleury-Souverain S.

Electrophoresis. 2018 Oct;39(20):2512-2520. doi: 10.1002/elps.201800007. Epub 2018 Mar 1.

PMID:
29427392
4.

Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine.

Gorzkiewicz M, Jatczak-Pawlik I, Studzian M, Pułaski Ł, Appelhans D, Voit B, Klajnert-Maculewicz B.

Biomacromolecules. 2018 Feb 12;19(2):531-543. doi: 10.1021/acs.biomac.7b01650. Epub 2018 Jan 30.

PMID:
29323872
5.

Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Parker WB, Sorscher EJ.

Curr Pharm Des. 2017 Nov 8. doi: 10.2174/1381612823666171109101851. [Epub ahead of print]

6.

Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes.

de la Cruz A, Vera-Zambrano A, Peraza DA, Valenzuela C, Zapata JM, Perez-Chacon G, Gonzalez T.

Front Pharmacol. 2017 Mar 31;8:177. doi: 10.3389/fphar.2017.00177. eCollection 2017.

7.

Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene.

Wang X, Sun L, Sun X, Yu J, Wang K, Wu Y, Gao Q, Zheng J.

Int J Oncol. 2017 May;50(5):1612-1622. doi: 10.3892/ijo.2017.3949. Epub 2017 Apr 4.

8.

Fludarabine resistance mediated by aminoglycoside-3'-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase.

Sánchez-Carrera D, Bravo-Navas S, Cabezón E, Arechaga I, Cabezas M, Yáñez L, Pipaón C.

FASEB J. 2017 Jul;31(7):3007-3017. doi: 10.1096/fj.201601245R. Epub 2017 Apr 3.

PMID:
28373209
9.
10.

6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.

Hassan AEA, Abou-Elkhair RAI, Parker WB, Allan PW, Secrist JA 3rd.

Eur J Med Chem. 2016 Jan 27;108:616-622. doi: 10.1016/j.ejmech.2015.12.029. Epub 2015 Dec 17.

PMID:
26724729
11.

Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria.

Lehouritis P, Stanton M, McCarthy FO, Jeavons M, Tangney M.

J Control Release. 2016 Jan 28;222:9-17. doi: 10.1016/j.jconrel.2015.11.030. Epub 2015 Dec 2.

PMID:
26655063
12.

Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients.

McCune JS, Mager DE, Bemer MJ, Sandmaier BM, Storer BE, Heimfeld S.

Cancer Chemother Pharmacol. 2015 Jul;76(1):85-96. doi: 10.1007/s00280-015-2768-x. Epub 2015 May 17.

13.

Apoptosis-induced activation of HIV-1 in latently infected cell lines.

Khan SZ, Hand N, Zeichner SL.

Retrovirology. 2015 May 16;12:42. doi: 10.1186/s12977-015-0169-1.

14.

Phospholipid derivatives of cladribine and fludarabine: synthesis and biological properties.

Tsybulskaya I, Kulak T, Kalinichenko E, Baranovsky A, Bogushevich S, Golubeva M, Kuzmitsky B.

Bioorg Med Chem. 2015 Jul 1;23(13):3287-96. doi: 10.1016/j.bmc.2015.04.059. Epub 2015 Apr 25.

PMID:
25960323
15.

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.

McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.

Cancer Chemother Pharmacol. 2015 Jan;75(1):67-75. doi: 10.1007/s00280-014-2618-2. Epub 2014 Nov 6.

16.

Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.

Pessetto ZY, Ma Y, Hirst JJ, von Mehren M, Weir SJ, Godwin AK.

Mol Cancer Ther. 2014 Oct;13(10):2276-87. doi: 10.1158/1535-7163.MCT-14-0043. Epub 2014 Aug 13.

17.

Corticosteroid-responsive pulmonary toxicity associated with fludarabine monophosphate: a case report.

Rudzianskiene M, Griniute R, Juozaityte E, Inciura A, Rudzianskas V, Emilia Kiavialaitis G.

Turk J Haematol. 2012 Dec;29(4):392-6. doi: 10.5505/tjh.2012.50490. Epub 2012 Dec 5.

18.

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.

Bemer MJ, Sorror M, Sandmaier BM, O'Donnell PV, McCune JS.

Cancer Chemother Pharmacol. 2013 Sep;72(3):607-18. doi: 10.1007/s00280-013-2232-8. Epub 2013 Aug 2.

19.

Drug repurposing for gastrointestinal stromal tumor.

Pessetto ZY, Weir SJ, Sethi G, Broward MA, Godwin AK.

Mol Cancer Ther. 2013 Jul;12(7):1299-309. doi: 10.1158/1535-7163.MCT-12-0968. Epub 2013 May 8.

20.

Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models.

Waud WR, Gilbert KS, Secrist JA 3rd.

Nucleosides Nucleotides Nucleic Acids. 2012;31(9):647-60.

PMID:
23004929

Supplemental Content

Loading ...
Support Center